Screener
Medtronic MDT Other Operating Segments, Including Diabetes — Net Sales
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Medtronic in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Medtronic’s 10-K, filed June 18, 2026.
- Filed
- Jun 18, 2026, 4:27 PM EDT
- Fiscal year
- FY2026
- Accession
- 0001628280-26-044354
| (in millions) | Cardiovascular | Neuroscience | Medical Surgical | Total |
|---|---|---|---|---|
| Net sales | $13,976 | $10,287 | $8,815 | $33,079 |
| Reconciliation of revenues | ||||
| Other operating segments net sales(1) | 3,247 | |||
| Other adjustments(2) | 39 | |||
| Total consolidated net sales | $36,364 | |||
| Less: | ||||
| Cost of products sold, excluding amortization of intangible assets | 4,695 | 3,151 | 3,476 | 11,323 |
| Research and development expense | 1,136 | 616 | 686 | 2,438 |
Item 8. Financial Statements and Supplementary Data
FAQ
- What is Medtronic's other operating segments, including diabetes — net sales?
- Medtronic (MDT) reported other operating segments, including diabetes — net sales of $811.75M in Q1 2026.
- How has Medtronic's other operating segments, including diabetes — net sales changed year-over-year?
- Medtronic's other operating segments, including diabetes — net sales increased by 12.3% year-over-year, from $723M to $811.75M.
- What is the long-term trend for Medtronic's other operating segments, including diabetes — net sales?
- Over 2 years (2024 to 2026), Medtronic's other operating segments, including diabetes — net sales has grown at a 9.5% compound annual growth rate (CAGR), from $2.71B to $3.25B.
- What does other operating segments, including diabetes — net sales mean?
- This metric represents the total revenue generated by the company's secondary business units, specifically including the diabetes care division. It captures the top-line performance of specialized medical device segments that fall outside the primary core business reporting lines. Monitoring this helps assess the growth trajectory and market adoption of niche therapeutic technologies.
Ask your AI about Medtronic's other operating segments, including diabetes — net sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude